In-vitro method for determining a surreptitious use of exogenous erythropoiesis stimulating agents by a normal living subject
US5369014A · kind A · utility
12Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 1992 |
| Grant date | Nov 29, 1994 |
| Priority date | — |
| Expiry date | Aug 17, 2012 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/901
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention is an in-vitro blood assay method for determining the past and/or present use of exogenous erythropoietin by a living subject. The blood assay method detects, identifies, and determines the consequences of using an exogenous erythropoietin to generate an increase in red blood cell production in the living subject and provides a methodology by which to detect and determine both surreptitious as well as authorized therapeutic uses and applications of erythropoietin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.